Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
aTyr Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
aTyr Pharma Raises USD76 Million in Series E Financing 11
aTyr Pharma Raises US$49 Million In Series D Financing 13
Partnerships 14
Pangu BioPharma Renews Agreement with Hong Kong University of Science and Technology 14
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 15
Equity Offering 17
aTyr Pharma Plans to Raise up to USD72 Million in Public Offering of Shares 17
aTyr Pharma Raises USD45.8 Million in Private Placement of Shares, Preferred Shares and Warrants 18
aTyr Pharma to Raise up to USD20 Million in Public Offering of Shares 20
aTyr Pharma Raises USD86.3 Million in IPO of Shares 21
aTyr Pharma Inc – Key Competitors 23
aTyr Pharma Inc – Key Employees 24
aTyr Pharma Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 14, 2018: aTyr Pharma announces second quarter 2018 operating results and provides corporate update 26
May 14, 2018: aTyr Pharma Announces First Quarter 2018 Operating Results, Program Prioritization and Corporate Restructuring 28
Mar 19, 2018: aTyr Pharma Announces Fourth Quarter and Year-End 2017 Operating Results and Provides Corporate Update 29
Nov 14, 2017: aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update 31
Aug 14, 2017: aTyr Pharma Announces Second Quarter 2017 Operating Results and Provides an Update on Innovative Immunology Pipeline 33
May 11, 2017: aTyr Pharma Announces First Quarter 2017 Operating Results 35
Mar 16, 2017: aTyr Pharma Announces Fourth Quarter and Year-End 2016 Operating Results 37
Corporate Communications 39
Oct 15, 2018: aTyr Pharma announces leadership transition 39
Jul 31, 2018: aTyr pharma appoints Jill Broadfoot as chief financial officer 40
Nov 01, 2017: aTyr Pharma Announces Leadership Transition 41
Apr 10, 2017: aTyr Pharma Announces Appointment of Timothy P. Coughlin to its Board of Directors 42
Apr 03, 2017: aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors 43
Product News 44
12/21/2017: aTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology Symposium 44
09/27/2017: aTyr Pharma to Present Final Data for Resolaris Phase 1b/2 Trial in Patients with Early-Onset Facioscapulohumeral Muscular Dystrophy at the 22nd International Annual Congress of the World Muscle Society 45
05/15/2017: aTyr Pharma Announces Presentations on Interstitial Lung Disease and the iMod.Fc Program at the American Thoracic Society 2017 International Conference and Will Host an Educational Webinar 46
04/24/2017: aTyr Pharma Announces Promising Top-Line Results from Resolaris Phase 1b/2 Clinical Trial in Patients with Early Onset Facioscapulohumeral Muscular Dystrophy 47
04/24/2017: aTyr Pharma Presents Analyses of Resolaris Phase 1b/2 Trial in Patients with Limb Girdle Muscular Dystrophy 2B and Facioscapulohumeral Muscular Dystrophy at the American Academy of Neurology 69th Annual Meeting 48
Product Approvals 49
Mar 03, 2017: aTyr Pharma Receives EMA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris 49
Feb 28, 2017: aTyr Pharma Receives U.S. FDA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy with Resolaris 50
Jan 18, 2017: FDA Grants Fast Track Designation for aTyr’s Resolaris to Treat Limb Girdle Muscular Dystrophy 2B and Removes Partial Clinical Hold for Resolaris 51
Clinical Trials 52
Nov 27, 2017: aTyr Pharma Doses First Subjects in Phase 1 Trial of iMod.Fc (ATYR1923) 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
aTyr Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
aTyr Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 9
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
aTyr Pharma Raises USD76 Million in Series E Financing 11
aTyr Pharma Raises US$49 Million In Series D Financing 13
Pangu BioPharma Renews Agreement with Hong Kong University of Science and Technology 14
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 15
aTyr Pharma Plans to Raise up to USD72 Million in Public Offering of Shares 17
aTyr Pharma Raises USD45.8 Million in Private Placement of Shares, Preferred Shares and Warrants 18
aTyr Pharma to Raise up to USD20 Million in Public Offering of Shares 20
aTyr Pharma Raises USD86.3 Million in IPO of Shares 21
aTyr Pharma Inc, Key Competitors 23
aTyr Pharma Inc, Key Employees 24
aTyr Pharma Inc, Subsidiaries 25
List of Figures
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
aTyr Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9